Clinical Trials Directory

Trials / Completed

CompletedNCT04114916

Clinical Trial to Evaluate the Reduction of Cardiovascular Risk

Clinical Trial to Evaluate the Efficacy of a Nutraceutical Versus Placebo in Reducing Cardiovascular Risk in Healthy Subjects.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Universidad Católica San Antonio de Murcia · Academic / Other
Sex
Female
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

Randomized parallel and double blind clinical trial in which it is intended to analyze the efficacy of a nutraceutical on cholesterol and endothelial function after the consumption of a product for eight weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTApigenin, luteonin, grapefruit extract and citroliveTwo capsules daily at breakfast and dinner.
DIETARY_SUPPLEMENTmaltodextrinaTwo capsules daily at breakfast and dinner.

Timeline

Start date
2016-10-01
Primary completion
2018-12-22
Completion
2018-12-30
First posted
2019-10-03
Last updated
2019-10-03

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04114916. Inclusion in this directory is not an endorsement.

Clinical Trial to Evaluate the Reduction of Cardiovascular Risk (NCT04114916) · Clinical Trials Directory